Tesamorelin/Ipamorelin 12/2MG
The TESA-IPA peptide blend pairs Tesamorelin with Ipamorelin, providing a complementary model for examining growth hormone release and its influence on metabolic activity, tissue recovery, and cellular processes in research environments.
Tesamorelin acts as a GHRH analog, engaging pituitary pathways to promote GH-related signaling.
Ipamorelin targets ghrelin receptors, enabling selective and controlled stimulation of GH release.
Together, the blend supports studies involving muscle development, fat utilization, and sleep-related regulatory mechanisms.